Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Charts show an easy double, Little resistance.
Great news has not changed from yesterday. Charts show a gradual move to New Highs. Now we also have the news.
The science looks amazing, Imo way undervalued even at the $3 price target !
So start of Rhetts trial should be announced soon, Pk data, Parkinsons and AD. Next 6 months will be wild. Great strategy to get us to market the fastest. Sorry Shorts, not going to take as long as you wished.
Wow. Charts show no major resistence until $30 area.
Medical Radioactive Counter Measure !
Big 9 months of news coming. Cannot make money in the bank now. So I am investing.
ASCO booth #2062 June 2-6 across from MERCK.
Large ASCO booth #7152 and smaller #10161 near food court.
UP a $1 Tomorrow??
Seems like they need to fill very Large buy orders. The apparent run up each day and accumulate as much stock during the day from sellers and shorts before running it up the end of day and following days, this could last for weeks. Usually occurs before big events imo.
So it seems the SEC is finally looking at Bloggers like SA, Motley Fool and Street. com and watching the negative articles and bashing by these posters. We don't need paid pumpers or paid bashers. I think the days of easy money by short attacks and their circle of friends may be over.
A safe CNS drug ? And one that can treat Millions in various diseases WORLDWIDE. I would be buying anything below $20. People are asking how they can get it already !
Charts show move to $44 before any big resistence.
Amazon has BIG plans for PLUG going forward. 10x bagger imo.
Orphan drug designation and a tiny 500k float !
Looks like same AMAZING news : ALZ patients stable after a full year with a subset returning to normal baseline! This alone should be trading at $50. Then add in moving to phase 2 trials ins Rhetts and Parkinson $60, then add in Phase 2/3 trials beginning this year $70, BIIB testing, add in a poison pill and plenty of cash, $75 fair value now.
Unfortunetly I dont think we gain too much without PFS (progression free survival) data. FDA rarely approves without it. And with 120 million shares in the float I don't expect much of a move.
Let me clear this up, and you can watch the slideshow from the Oppenheimer conference on the website, there are to be updateS (plural) of the 104 week extension. NOT just at 104 weeks !
Wow. MGEN just receives FDA orphan drug designation ! Micro float of only 500k vs. AKTX 3 million float.
Upcoming Billion dollar slogan: Relax with Anavax !
In a previous MJFF-sponsored project, we evaluated PRE-084 (an experimental compound binding to the sigma-1 receptor) in pre-clinical models of Parkinson’s disease. Chronic treatment with PRE-084 produced a gradual improvement of motor deficits and activated molecules involved in brain repair. In this project, we will evaluate a sigma-1 receptor agonist (ANAVEX2-73) produced by Anavex, which is now being evaluated in patients with Alzheimer’s disease. In our experimental study, the efficacy of ANAVEX2-73 on Parkinson’s biology will be compared to that of PRE-084 and other Sig-1R ligands.
If successful, this study will accelerate the translation of pre-clinical findings into the first clinical trial of ANAVEX2-73 as a potential disease-modifying therapy for Parkinson’s disease. ANAVEX2-73 has already been tested for safety and tolerability in humans with positive results.
Tiny float and now in major brand stores selling cholestrol test ! $25+ imo.
Imo, 15 month data and PK data come after poison pill is implemented after April 18th Annual meeting. This news will also assist in the issuance of the preferred. The raise will not dilute and give us plenty of funds to start all trials. Just 12 weeks after Parkinson and Rhetts trials begin we will get results. Prepare for the climb.
Any day now we get Parkinson start and Rhetts start and ALZ phase2/3 news. Also PK data so design trial with FDA is well planned, poison pill too. I can wait 6 months to a year easy for this news. In between I will just buy on dips. Top CNS drug imo.
Conference first week of April and MS data last week of April. $25?
2nd and 3rd quarters will be filled with news. A bank cd at .075% or AVXL? My requirements to short a stock are extremely weak here and profits limited. Rather build on long position here.
Moving to AVXL, Alzheimer update soon and poison pill added at annual meeting vote !
Conference call highlights:
Parkinsons: Strong behavior response, cells actually grow back and reduction in inflammation
Alzheimers: Dr. Missling reports they held phase 2 studies to set up failure so they could find out without putting out tons of money or being unethical toward patient population, if the drug works. (Guess what it seems to work.) So phase 3 he says should always be , with the upcoming PK date, to CONFIRM phase 2 results. Sounded very confident.
Parkinson and Rhetts : Both foundations have never seen results like these before and thus helping to fund trials.
What is coming: Updates(plural) on the 104 week extension on Alzheimers Disease, PK/PD data, Rhetts phase 2. Parkinson phase2, AD phase 2/3 and possible results end of 2017 early 2018 on rhetts trial (only 12 week trial) same length on Parkinsons
Important info:
3.7 BILLION dollar market
1100 MRI systems get replaced annually
Imo a 10 bagger.
I can wait 8 months for a potential 10 bagger! Where else can you make 100%+? Not in the bank. Rhetts results by the end of 2017 or early 2018. MJFF and Rhett Foundations never seen such results! And they are setting up phase 3 in AD for complete success. Very informative presentation to the masses. And we know more is coming.
Conference: Dr. Missling says that phase 3 in AD should be always a confirmatory study based on the tough criteria they set up for phase 2 failure. They would rather set up the drug to fail in phase 2 so they would save money and for ethical patient reasons.( Did not fail in phase2) Also the PK data coming will be used to determine whom benefited the most and set up Phase 3 in those type of patients. SO it seems to me they will be setting up Phase 3 for major success ! Also noted, he said 1/3 of the patients improved above baseline established a year ago. THAT'S UNHEARD OF.
$75+
We can see $1-$2 daily jumps in price !
Poison Pill, ACQUISITION EVENT
Subject to the terms of the Shareholder Rights Plan, in the event any person shall become an Acquiring Person, then, the Company will take such action as to ensure each holder of a Right will thereafter have the right to receive, upon exercise, Common Stock (or, in certain circumstances, cash, property, or other securities of the Company) having a value equal to two times the exercise price of the Right.
Acquiring Person shall become null and void without any further action, and any holder of such Rights shall not have any right whatsoever to exercise such Rights under the Shareholder Rights Plan and shall not have thereafter any right whatsoever with respect to such Rights.
So does that mean if AVXL makes the exercise price of the right $10, then we are entitled to 2x that amount or $20? or $30 and $60 etc etc. $50 and $100.
Annual Meeting is on April 18th ! Just in a few weeks in NYC.
Wow:
AVXL already stabilized AD after 12 months and will update 15 mo results end of March ! Working with Michael j Foxx foundation in Parkinsons and BIIB evaluating the drug for MS. Visit their website and see latest video presentation.
Three HUGE biotechs: AVXL, TGTX and KITE.. Small market caps with tremendous growth in successful trials in Alzheimers, Leukemia and Lymphoma! Compare to MC of BIIB and GILD each with 95 billion !
Only 4 Billion Market Cap, BIIB and GILD each have 94 Billion MC. Thus a looong climb higher.
This medical breakthrough is worth north of $50-$70
On its way to $50+